Kawagoe Tetsuro, Maruki Yuta, Nagoya Hiroyuki, Kosugi Yuki, Akimoto Teppei, Yamawaki Hiroshi, Kodaka Yasuhiro, Shimpuku Mayumi, Ueki Nobue, Futagami Seiji, Miyake Kazumasa, Iwakiri Katsuhiko
Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School.
J Nippon Med Sch. 2016;83(5):199-202. doi: 10.1272/jnms.83.199.
An 81-year-old man was admitted with upper abdominal pain and weight loss. Esophagogastroduodenoscopy revealed a large tumor located from the gastric angle to the body. Histological analysis of a biopsy revealed a moderately differentiated adenocarcinoma. Computed tomography revealed metastases in the liver and lung and the patient was subsequently diagnosed with metastatic advanced gastric cancer. He was treated with chemotherapy using S-1 (80 mg/m) and cisplatin (CDDP) (60 mg/m). Twenty-two months after chemotherapy, the gastric tumor, and the nodules in the liver and lung, had disappeared. We subsequently diagnosed a clinical complete response. The patient was treated with further S-1 monotherapy for 7 months after complete response assessment. He has lived for more than 7 years since the initial diagnosis without recurrence. Chemotherapy using S-1 and CDDP may be a potent strategy for improving survival in elderly patients with advanced gastric cancer.